Nuclear Science and Techniques

《核技术》(英文版) ISSN 1001-8042 CN 31-1559/TL     2019 Impact factor 1.556

Nuclear Science and Techniques ›› 2012, Vol. 23 ›› Issue (5): 305-311 doi: 10.13538/j.1001-8042/nst.23.305-311

• RADIOCHEMISTRY, RADIOPHARMACEUTICALS AND NUCLEAR MEDICIN • Previous Articles     Next Articles

Preoperative detecting metastases of cervical cancer in pelvic and para-aortic lymph nodes:comparison of integrated 18F-FDG PET/CT with or without contrast enhancement

XING Yan ZHAO Jinhua* SONG Jianhua CHEN Xiang QIAO Wenli   

  1. Department of Nuclear Medicine, Shanghai First People’s Hospital, Shanghai Jiao Tong University, Shanghai 200080, China
PDF ShareIt Export Citation
XING Yan, ZHAO Jinhua, SONG Jianhua, CHEN Xiang, QIAO Wenli . Preoperative detecting metastases of cervical cancer in pelvic and para-aortic lymph nodes:comparison of integrated 18F-FDG PET/CT with or without contrast enhancement.Nuclear Science and Techniques, 2012, 23(5): 305-311     doi: 10.13538/j.1001-8042/nst.23.305-311

Abstract:

Purpose: Compared the performance of contrast-enhanced PET/CT and non-enhanced PET/CT for preoperatively detecting pelvic and para-aortic lymph node metastases in patients with cervical cancer. Methods: This prospective study included 72 patients with clinically M0 cervical cancer. They underwent surgery within two weeks of PET/CT imaging. Imaging consisted of a whole-body PET/CT protocol without intravenous contrast, followed by abdominal and pelvic PET/CT protocol including contrast-enhanced CT. We compared the diagnostic efficiency between the methods on per-patient and per-lesion basis. Results: Patient-based analysis showed that the sensitivity, specificity, and accuracy of contrast-enhanced PET/CT were 63.6% (14/22), 94.0% (47/50), and 84.7%(61/72), respectively, whereas those of non-enhanced PET/CT were 54.5% (12/22), 88.0% (44/50), and 77.8% (56/72), respectively, and those of enhanced CT alone were 36.4% (8/22), 80.0% (40/50), and 66.7% (48/72), respectively. Lesion-based analysis showed that the sensitivity, specificity, and accuracy of contrast-enhanced PET/CT were 77.7% (87/112), 98.7%(938/950), and 96.5% (1025/1062), respectively, whereas those of non-enhanced PET/CT were 69.6% (78/112), 97.5% (926/950), and 94.5% (1004/1062), respectively, and those of enhanced CT were 54.4% (61/112), 96.1% (913/950), and 91.7% (974/1062), respectively. Contrast-enhanced PET/CT had the best sensitivity, specificity and accuracy. Although patient-based analysis showed no significant difference between contrast-enhanced PET/CT and non-enhanced PET/CT (p =0.540, 0.295 and 0.286), the specificity and accuracy of these two methods were significantly different on lesion-based analysis (p =0.043 and 0.027).

Key words: Uterine cervical cancer, Nodal staging, FDG, PET/CT, Contrast enhanced CT